文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

在一个由730236人组成的真实世界一级预防队列中,血脂水平对冠心病的绝对影响。

Absolute impact of lipid levels on coronary heart disease in a real-world primary prevention cohort of 730,236 people.

作者信息

Alves-Cabratosa Lia, Guzmán Lidia, Blanch Jordi, Comas-Cufí Marc, García-Gil María, Zacarías-Pons Lluís, Martí-Lluch Ruth, Ponjoan Anna, Domínguez-Armengol Gina, Ribas-Aulinas Francesc, Tornabell-Noguera Èric, García-Ortiz Luis, Ramos Rafel

机构信息

Grup d'Investigació en Salut Vascular de Girona (ISV-Girona), Institut Universitari d'Investigació en Atenció Primària Jordi Gol i Gurina -IDIAPJGol, C/ Maluquer Salvador, 11, 17002-Girona, Catalonia, Spain.

Network for Research on Chronicity, Primary Care, and Prevention and Health Promotion (RICAPPS), C/ Maluquer Salvador, 11, 17002, Girona, Spain.

出版信息

Am J Prev Cardiol. 2025 Jul 21;23:101059. doi: 10.1016/j.ajpc.2025.101059. eCollection 2025 Sep.


DOI:10.1016/j.ajpc.2025.101059
PMID:40777544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12329289/
Abstract

BACKGROUND AND AIMS: The impact of the association of LDL-c levels with coronary heart disease is unambiguous in people with previous cardiovascular disease. In primary prevention, however, it has been poorly studied. We analyzed the impact of the association of lipid levels with coronary heart disease in a population with no previous cardiovascular disease. We included potential variations by sex and age. METHODS: Retrospective cohort analysis of records from the SIDIAP Catalan database, Spain. We selected ≥35-year-olds without previous cardiovascular disease or lipid-lowering medications. The LDL, HDL, and triglycerides levels were the exposure and coronary heart disease was the outcome. Cox regression and Lin additive models estimated the relative and absolute associations, respectively. RESULTS: We analyzed the records from 730,236 participants; follow-up: 6.7 years; mean (SD) age: 58.5 (13.9) years, and 42.2 % of them were men. The overall CHD incidence rate was 3.47 (3.42-3.52) events per 1000 person-years; it was higher in men than in women, with 4.98 (4.88-5.07) and 2.39 (2.33-2.45) events per 1000 person-years, respectively. One mmol/L increase in LDL-c, HDL-c, and TGs showed HRs (95 %CI) of 1.26 (1.24-1.29), 0.60 (0.57-0.63), and 1.16 (1.13-1.19), respectively. The absolute differences for LDL-c and TGs were less than one additional CHD event per 1000 person-years; and two fewer events for HDL-c. CONCLUSIONS: The moderate to low increment in the incidence of CHD by 1 mmol/L of lipid increase represented low numbers of additional events in this low-risk Mediterranean population.

摘要

背景与目的:低密度脂蛋白胆固醇(LDL-c)水平与冠心病之间的关联,在既往有心血管疾病的人群中已明确。然而,在一级预防中,相关研究较少。我们分析了在无心血管疾病病史人群中,血脂水平与冠心病之间关联的影响,并纳入了性别和年龄的潜在差异。 方法:对西班牙SIDIAP加泰罗尼亚数据库中的记录进行回顾性队列分析。我们选取了年龄≥35岁、无心血管疾病病史或降脂药物治疗史的人群。LDL、HDL和甘油三酯水平作为暴露因素,冠心病作为结局。Cox回归模型和线性相加模型分别估计相对关联和绝对关联。 结果:我们分析了730236名参与者的记录;随访时间为6.7年;平均(标准差)年龄为58.5(13.9)岁,其中42.2%为男性。冠心病总体发病率为每1000人年3.47(3.42 - 3.52)例;男性高于女性,分别为每1000人年4.98(4.88 - 5.07)例和2.39(2.33 - 2.45)例。LDL-c、HDL-c和甘油三酯每增加1 mmol/L,风险比(95%置信区间)分别为1.26(1.24 - 1.29)、0.60(0.57 - 0.63)和1.16(1.13 - 1.19)。LDL-c和甘油三酯每1000人年新增冠心病事件的绝对差异小于1例;HDL-c每1000人年减少2例。 结论:在这个低风险的地中海人群中,血脂每升高1 mmol/L,冠心病发病率适度至低度增加所导致的新增事件数量较少。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1e1/12329289/912ebcfa6089/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1e1/12329289/e093215f6ef1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1e1/12329289/035d1dd60427/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1e1/12329289/f9fc44bd45af/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1e1/12329289/912ebcfa6089/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1e1/12329289/e093215f6ef1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1e1/12329289/035d1dd60427/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1e1/12329289/f9fc44bd45af/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1e1/12329289/912ebcfa6089/gr4.jpg

相似文献

[1]
Absolute impact of lipid levels on coronary heart disease in a real-world primary prevention cohort of 730,236 people.

Am J Prev Cardiol. 2025-7-21

[2]
Replacing salt with low-sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women.

Cochrane Database Syst Rev. 2022-8-10

[3]
Long-term hormone therapy for perimenopausal and postmenopausal women.

Cochrane Database Syst Rev. 2017-1-17

[4]
Exercise-based cardiac rehabilitation for coronary heart disease.

Cochrane Database Syst Rev. 2016-1-5

[5]
Exercise-based cardiac rehabilitation for coronary heart disease.

Cochrane Database Syst Rev. 2021-11-6

[6]
Patient education in the management of coronary heart disease.

Cochrane Database Syst Rev. 2017-6-28

[7]
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.

Cochrane Database Syst Rev. 2022-2-24

[8]
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Cochrane Database Syst Rev. 2021-4-19

[9]
Tai chi for primary prevention of cardiovascular disease.

Cochrane Database Syst Rev. 2014-4-9

[10]
Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.

Health Technol Assess. 2013-9

本文引用的文献

[1]
2024 ESC Guidelines for the management of elevated blood pressure and hypertension.

Eur Heart J. 2024-10-7

[2]
Sex matters in the association between cardiovascular health and incident dementia: evidence from real world data.

Alzheimers Res Ther. 2024-3-14

[3]
Consensus document for lipid profile testing and reporting in Spanish clinical laboratories: What parameters should a basic lipid profile include?

Rev Clin Esp (Barc). 2023

[4]
Association of Low-Density Lipoprotein Cholesterol with Risk of Coronary Heart Disease and Stroke among Middle-Aged Japanese Workers: An Analysis using Inverse Probability Weighting.

J Atheroscler Thromb. 2023-5-1

[5]
Data Resource Profile: The Information System for Research in Primary Care (SIDIAP).

Int J Epidemiol. 2022-12-13

[6]
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.

Eur Heart J. 2021-9-7

[7]
Low-density lipoprotein cholesterol and all-cause mortality: findings from the China health and retirement longitudinal study.

BMJ Open. 2020-8-16

[8]
Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.

Lancet. 2020-5-20

[9]
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk.

Atherosclerosis. 2019-11

[10]
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

J Am Coll Cardiol. 2019-9-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索